Renown Institute for Heart& Vascular Health — Reno, Nevada

Renown Institute for Heart& Vascular Health is a clinical research site located in Reno, Nevada, United States 89502.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Renown Institute for Heart& Vascular Health has participated in 7 clinical trials with 5 currently active.

Therapeutic areas: COVID-19 Pneumonia, Acute Respiratory Distress Syndrome (ARDS), ARDS.

Sponsors: Hoffmann-La Roche, PPD Development, LP, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Reno

Browse all research sites in Nevada · View every site in Reno

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Renown Institute for Heart& Vascular Health?

Renown Institute for Heart& Vascular Health has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Renown Institute for Heart& Vascular Health conducted?

Renown Institute for Heart& Vascular Health has 7 clinical trials on record, with 5 currently active. Their work covers COVID-19 Pneumonia, Acute Respiratory Distress Syndrome (ARDS), ARDS.

Is Renown Institute for Heart& Vascular Health accredited by Crixeo Clinical Trials?

Renown Institute for Heart& Vascular Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Renown Institute for Heart& Vascular Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.